Regent of University of California System has approved UCLA Health to set up a joint venture with Centre Testing International on January 22,2014.The agreement was signed on April 8,2014,aiming to operate a clinical laboratory in Shanghai.The new company,CTI Pathology/UCLA Health will greatly enhance medical care,support clinical trials and promote medical education in China.
At the signing ceremony for UCLA-CTI joint venture in Shanghai are Sangem Hsu (left seated), president of CTI, and Dr David Feinberg (right seated), president of UCLA Health System, with (from left) Ren Sun and Dr Jianyu Rao (both from UCLA), Paul Fasi (CTI), Dr Scott Binder, Dr Jonathan Braun and Dr Tom Rosenthal (all of UCLA).
"CTI has decided to establish a high-end third-party clinical medical laboratory 3 years ago.We have contacted with many well-kown USA agencies during the past years,and today we draw a perfect full stop,"said Sangem Hsu,president of CTI."UCLA Health is the best comprehensive hospital in western United States,and ranks the first in the patient satisfaction.Famous business critic Joseph Michelli has commented on UCLA Health in Prescription for Excellence that its excellence is due to 3 factors,Apple's innovation,NASA's safety awareness and Carlton's six-star service. UCLA Health pathology,the main collaboration body with CTI,has more than 1200 experts across an astounding range of disciplines,especially in molecular diagnosis.We hope our cooperation could contribute to China's medical test, clinical and pathological diagnosis,and provide high quality service for patients.We also appreciate the understanding and support from Shanghai authorities. "
"This joint venture is founded on UCLA's desire to build strong global relationships that, through education,research and service, improve the health of people and communities throughout the world,"said Dr. Tom Rosenthal, chief medical officer for UCLA Health System and co-director of UCLA's Center for World Health.
"CTI will be an outstanding partner in our effort to significantly improve patient care in China," said Dr.Scott Binder, senior vice chair of pathology and laboratory medicine at the Geffen School of Medicine."UCLA medical centre has a long-term cooperation with the second affiliated hospital of Zhejiang University and Chinese academy of medical sciences,so we have a clear understanding of China's medical and health development. There is a further development and improvement for China in the disciplines of immunohistochemistry,molecular pathology,flow cytometry and cytogenetics."Scott Binder also believed that the partnership will create a lot of medical education chance. UCLA has already hosted Chinese pathologists and technologists for training on specialized diagnostics for skin, blood and brain tissue and other areas.
About UCLA Health System
UCLA Health System for more than half a century has provided the best in health care and the latest in medical technology to the people of Los Angeles and the world. Comprising Ronald Reagan UCLA Medical Center; UCLA Medical Center, Santa Monica; the Resnick Neuropsychiatric Hospital at UCLA; Mattel Children's Hospital UCLA;the UCLA Medical Group and a wide network of primary care and specialty care offices throughout the region,UCLA Health is among the most comprehensive and advanced health care systems in the world.For more information, please visit www.uclahealth.org.
CTI,a publicly traded company on the Shenzhen Stock Exchange, is China's leading product testing, inspection,certification and consulting firm. Providing comprehensive services for consumer products in nearly every industry, CTI oversees quality control and enables companies to sell their products to markets worldwide.
For more information, please visit www.cti-cert.com.
For more details,please contact: